STAT3 and cancer: The best characterized activity of STAT3 in cancer is that of a constitutively tyrosine phosphorylated transcription factor as a result of de-regulated cytokine secretion (e.g IL-6 [5,6]) or mutations in tyrosine kinases including FLT3, EGFR, Src and JAK2 [3,7].